---
title: "MPCSH: Vice General Manager Wang Ruoqiang resigned due to work reasons"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/257491353.md"
description: "On September 16th, MPCSH announced that the company's board of directors received a written resignation letter from Deputy General Manager Wang Ruoqiang. Due to work reasons, Wang Ruoqiang applied to resign from the position of Deputy General Manager. Wang Ruoqiang's resignation letter will take effect from the date it is delivered to the company's board of directors. After resigning from the position of Deputy General Manager, Wang Ruoqiang will no longer hold any position in the company or its holding subsidiaries"
datetime: "2025-09-16T07:52:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257491353.md)
  - [en](https://longbridge.com/en/news/257491353.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257491353.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/257491353.md) | [繁體中文](https://longbridge.com/zh-HK/news/257491353.md)


# MPCSH: Vice General Manager Wang Ruoqiang resigned due to work reasons

On September 16th, MPCSH announced that the company's board of directors received a written resignation letter from the company's deputy general manager, Wang Ruoqiang. Due to work reasons, Wang Ruoqiang applied to resign from the position of deputy general manager. Wang Ruoqiang's resignation letter will take effect from the date it is delivered to the company's board of directors. After resigning from the position of deputy general manager, Wang Ruoqiang will no longer hold any positions in the company or its holding subsidiaries

### 相关股票

- [MPCSH (000637.CN)](https://longbridge.com/zh-CN/quote/000637.CN.md)

## 相关资讯与研究

- [BYD reportedly explores F1 entry to boost global brand appeal](https://longbridge.com/zh-CN/news/278576491.md)
- [Bessent, on safe passage of ships in Strait of Hormuz, says U.S. is on track to get this solved](https://longbridge.com/zh-CN/news/278171367.md)
- [Junshi Biosciences’ Subcutaneous Toripalimab NDAs Accepted in China](https://longbridge.com/zh-CN/news/278445287.md)
- [13:46 ETNanchang Optoelectronic Industry Cluster brilla en ISLE 2026](https://longbridge.com/zh-CN/news/278597263.md)
- [Kainova Therapeutics reports positive phase 1 results for DT‑9081 in advanced solid tumours](https://longbridge.com/zh-CN/news/278526333.md)